Fidelity Top Stories
US manufacturing strengthens in September, Philly Fed says
Manufacturing sector conditions in the US mid-Atlantic region continued to firm in September, the results of a closely-followed survey revealed.
Illness in phase three trial not linked to Covid-19 vaccine, Oxford says
The Covid19 vaccine being trialled by AstraZeneca and the University of Oxford was likely not behind the symptoms of one participant which led to the pause in the phase three trials last week, documents provided to the volunteers show.
Novacyt swings to profit on soaring Covid test sales
Covid-19 test maker Novacyt swung to a first-half profit driven by soaring sales during the current pandemic and said it expected core annual earnings to top €100m.
Hilton Foods lifts dividend as home dining boosts profits
International food packing business Hilton Food lifted its dividend after a sharp rise in interim profits driven by higher volumes.
Oxford Biomedica sees swing to FY profit on Covid vaccine hopes
Drugs maker Oxford Biomedica, which has partnered with pharma giant AstraZeneca to develop a Covid-19 vaccine, said it expected higher second half revenues to push it to a low-to-single digit full year profit.